Ramiz Nathani, PhD
2x founder, product leader, builder with technical depth and scientific background
About me
I build consumer apps for complex domains through intuitive digital platforms. From idea to millions of users, I create high-performing technical teams across complex technology sectors.
My expertise lies in combining product strategy, design, engineering excellence, and data science to solve complex challenges while delivering exceptional user experiences.
Location
Core Competencies
My expertise spans across product, technical leadership, and business domains.
Product Leadership
Technical Leadership
Business & Commercial
Ventures & Products
Founding and scaling innovative technology companies and products.
HemeHealth (now allmyhealth)
Co-Founder & CEO
Built a patient-owned health record platform enabling individuals to control their complete medical data, including imaging records. Raised $2M in funding (Venture Builder – Blenheim Chalcot, London) and scaled to 60,000+ users and 250+ healthcare providers in India and UK.
More InformationKey Metrics
Researcher
Co-Founder & CPTO
Conceptualized and built an academic discovery platform transforming how scholars access scientific literature. Raised $3.5M in funding and scaled to 3M users with 100M+ papers accessed through the platform.
More InformationKey Metrics
Research & Patents
Scientific contributions and intellectual property.
Method of Characterizing a Polynucleotide
US 11,920,193 B2, 2024
This patent describes methods for characterizing double-stranded polynucleotides using a detector, such as a nanopore, without the need for a hairpin connecting the template and complement strands. It also details the use of tag-modified nanopores for increased sensitivity and throughput.
Mutant Pore
US 11,939,359 B2, 2024
This invention relates to mutant forms of lysenin and their application in analyte characterization using these mutant forms.
Methods and Systems for Characterizing Analytes Using Nanopores
US 11,466,317 B2, 2022
This patent outlines methods for characterizing analytes using nanopores, including techniques for analyzing double-stranded polynucleotides without hairpin connectors and utilizing tag-modified nanopores for enhanced sensitivity.
Mutant Pore
US 11,104,709 B2, 2021
This invention pertains to mutant forms of lysenin and their use in analyte characterization.
Methods and Systems for Characterizing Analytes Using Nanopores
US 2023/0084931 A1 (Publication), 2023
This application describes methods for characterizing double-stranded polynucleotides using nanopores without hairpin connectors and the use of tag-modified nanopores for increased sensitivity and throughput.
Mutant Pore
US 2022/0064230 A1 (Publication), 2022
This application pertains to mutant forms of lysenin and their use in analyte characterization.
Professional Experience
My journey across research, industry, and entrepreneurship.
Co-Founder & CEO
HemeHealth (now allmyhealth)
Built a patient-owned health record platform enabling individuals to control their complete medical data, including imaging records. Raised $2M in funding and scaled to 60,000+ users and 250+ healthcare providers.
Co-Founder & CPTO
Researcher
Conceptualized and built an academic discovery platform transforming how scholars access scientific literature. Raised $3.5M in funding and scaled to 3M users with 100M+ papers accessed through the platform.
Research Scientist
Oxford Nanopore Technologies
Built data analysis pipelines that processed millions of data point, improving analysis speed 5x compared to existing approaches that were being used.
Research Associate
University College London
Led research on targeted anti-cancer therapies using antibody-drug conjugates. Secured £120,000 in proof-of-concept funding through compelling commercialization strategy.
Education
Academic foundation in chemical biology and engineering.
PhD, Chemical Biology
University College London
Thesis: "Site-Selective Protein Modifications for Therapeutic Applications"
Developed novel chemical approaches for precise protein modification with application in drug development.
MSc, Chemical Research
University College London
Distinction
Specialized in bio-orthogonal chemistry and protein engineering.
Bachelor of Technology
University of Mumbai
First Class, J.N. Tata Scholar
Specialized in Pharmaceutical Chemistry.
Get In Touch
Interested in discussing opportunities? Let's connect.